2 recruiting, 1 completed. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Completed 1 |
Follow Texas Southern University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure) Community Health Worker (CHW)/Social Worker (SW)-led non-medical health related needs (NMHRN) intervention + Clinician-Led Medication Therapy Management (MTM) with remote blood pressure monitoring, Active Comparator (Control group) - Hypertensive Disorders of Pregnancy, Chronic Hypertension in Pregnancy | Not applicable | Recruiting | Texas Southern University | 158 | 2026-09-25 | 2026-10-14 |
| The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management. Pharmacists Only (Control Group), Combined Intervention (Pharmacists + CHW Interventions) - Hypertension | Not applicable | Recruiting | Texas Southern University | 480 | 2026-06-01 | 2026-04-13 |
| Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit Chlorhexidine gluconate, Standard bathing - Cross Infection, Pneumonia, Ventilator-associated | Not applicable | Completed | Joshua Swan | 350 | 2012-07-01 | 2018-04-27 |
Catheter-Related Infections (1) · Cross Infection (1) · Hypertension (1) · Hypertension, Pregnancy-Induced (1) · Pneumonia, Ventilator-Associated (1) · Pre-Eclampsia (1) · Surgical Wound Infection (1) · Urinary Tract Infections (1)
Control Groups (2) · Community Health Workers (1) · Methods (1) · Pharmacists (1) · chlorhexidine gluconate (1) · myotubularin (1)
United States (3)
Ivy O Poon, Pharm.D., M.S., BCPS (1) · Joshua T Swan, Pharm.D. (1) · Mark Ibarra-Garza, B.Sc, CCRP (1) · Veronica Ajewole-Mwema, PharmD, BCOP (1)
U54MD007605 (1)